Exploring the short-term influence of a proprietary oil extract of black cumin ( Nigella sativa ) on non-restorative sleep: a randomized, double-blinded, placebo-controlled actigraphy study

(black cumin, or black seed) is popularly known as the seed of blessings in the Arab system of medicine. Though not widely recommended for sleep, a unique proprietary black cumin extract (BlaQmax®/ThymoDream™; BCO-5) has been shown to be helpful in the management of stress and sleep issues. This ran...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in nutrition (Lausanne) Vol. 10; p. 1200118
Main Authors: Mohan, M E, Mohan, Mohind C, Prabhakaran, Prathibha, Syam Das, S, Krishnakumar, I M, Baby Chakrapani, P S
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media S.A 15-01-2024
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:(black cumin, or black seed) is popularly known as the seed of blessings in the Arab system of medicine. Though not widely recommended for sleep, a unique proprietary black cumin extract (BlaQmax®/ThymoDream™; BCO-5) has been shown to be helpful in the management of stress and sleep issues. This randomized, double-blind, placebo-controlled trial aimed to investigate the efficacy of BCO-5 on the sleep quality of volunteers characterized with a self-reported non-restorative sleep disorder. Healthy male and female participants ( = 70), aged 18-65 years (BMI 22-28 Kg/m ) were randomized to either placebo or BCO-5 ( = 35/group). Both interventions were supplemented at 200 mg/day for seven days. Actigraphy and a validated restorative sleep questionnaire (RSQ-W) were used to monitor the influence of BCO-5 on sleep. Compared to placebo, BCO-5 significantly improved sleep quality, as evidenced by both intra-group and inter-group analyses of the actigraphy data. The relative improvements observed were sleep efficiency (7.8%,  < 0.001), total sleep time (19.1%,  < 0.001), sleep onset latency (35.4%;  < 0.001), and wake-after-sleep-onset (22.5%;  < 0.001) compared with placebo. BCO-5 also improved sleep by 75.3% compared to baseline (  < 0.001) and by 68.9% compared to placebo (  < 0.001), when monitored by RSQ-W. BCO-5 was well-tolerated with no reports of side effects or toxicity. BCO-5 significantly improved non-restorative sleep in seven days, indicating its potential role as a natural sleep aid.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Aleksandar Ž. Kostic, University of Belgrade, Serbia
Reviewed by: Marie-Pierre St-Onge, Columbia University, United States; María Fernanda Zerón-Rugerio, University of Barcelona, Spain; Naina Mohamed Pakkir Maideen, Dubai Academic Health Corporation, United Arab Emirates; Parichehr Hayatdavoudi, Mashhad University of Medical Sciences, Iran
ISSN:2296-861X
2296-861X
DOI:10.3389/fnut.2023.1200118